Cargando…
A novel metabolic gene signature-based nomogram to predict overall survival in breast cancer
BACKGROUND: Breast cancer risk prediction is often based on clinicopathological characteristics despite the high heterogeneity derived from gene expression. Metabolic alteration is a hallmark of cancer, and thus, the integration of a metabolic signature with clinical parameters is necessary to predi...
Autores principales: | Sun, Xi, Zhou, Zhi-Rui, Fang, Yan, Ding, Shuning, Lu, Shuangshuang, Wang, Zheng, Wang, Hui, Chen, Xiaosong, Shen, Kunwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033348/ https://www.ncbi.nlm.nih.gov/pubmed/33842588 http://dx.doi.org/10.21037/atm-20-4813 |
Ejemplares similares
-
Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer
por: Ding, Shuning, et al.
Publicado: (2021) -
Identification of Ten Mitosis Genes Associated with Tamoxifen Resistance in Breast Cancer
por: Sun, Xi, et al.
Publicado: (2021) -
Single‐cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy
por: Ding, Shuning, et al.
Publicado: (2020) -
A Potential Four-Gene Signature and Nomogram for Predicting the Overall Survival of Papillary Thyroid Cancer
por: Ding, Ying, et al.
Publicado: (2022) -
A nomogram for predicting the risk of male breast cancer for overall survival
por: Wen, Yahui, et al.
Publicado: (2023)